Achieving New Share Target for Generics Will Be “Quite Difficult”: Hengrui Japan President

Makoto Shimada Achieving generic share targets of 70% and 80% will be difficult, said Makoto Shimada, president of the Japan unit of the Chinese drug maker Jiangsu Hengrui Medicine, in a recent interview with Jiho. Mr Shimada, who served as...read more